Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
This project shall be implemented through incorporation of a new joint venture company in Zambia
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Subscribe To Our Newsletter & Stay Updated